Stay updated on Teriflunomide in Pediatric MS Clinical Trial

Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T00:15:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study objectives and participant eligibility criteria for a clinical trial on teriflunomide in pediatric multiple sclerosis, while adding a new registry identifier and a revision number.
    Difference
    13%
    Check dated 2025-04-22T18:11:51.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025. However, there are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-04-08T09:39:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 6, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T07:44:56.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-03-03T22:25:52.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates for optional extension periods for young participants with teriflunomide, moving from 2024 to 2025, indicating a significant change in the timeline for these participants. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.
    Difference
    1%
    Check dated 2025-02-10T09:53:29.000Z thumbnail image

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.